feed,title,long_url,short_url
MedRxiv,"A phase I/II clinical trial of intradermal, controllable self-replicating RNA vaccine EXG 5003 against SARS-CoV-2",https://medrxiv.org/cgi/content/short/2023.10.07.23296699v1?rss=1,https://da.gd/I0Cm
